Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    

 SummaryNewsCalendarCompanyFinancials 
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on... 
More about the company
Latest news on OSIRIS THERAPEUTICS, INC.
06/14 OSIRIS ANNOUNCES ELECTRONICALLY AVAI :   Open Surgical Implantation of a Viable ..
05/31 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial..
05/31 OSIRIS THERAPEUTICS : Appoints David White to its Board of Directors
05/19 OSIRIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
05/18 OSIRIS THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant (form ..
04/14 OSIRIS THERAPEUTICS : Announces Scientific Manuscript Comparing Impact of Preser..
04/13 Osiris Announces Scientific Manuscript Comparing Impact of Preservation Metho..
04/07 MEDIZONE INTERNATIONAL : Expands Board of Directors to Support Executing on the ..
04/06 MEDIZONE INTERNATIONAL : Expands Board of Directors to Support Executing on the ..
04/04 Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts,..
More news
Sector news : Bio Therapeutic Drugs
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
06/14 JOHNSON & JOHNSON : flu drug succeeds in mid-stage trial
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/28 Midday Gainers / Losers
03/28 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
03/21 After Hours Gainers / Losers
03/13 Midday Gainers / Losers
03/13 Trading in Osiris Therapeutics to be suspended tomorrow, formal delisting to ..
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
David A. Dresner President & Chief Executive Officer
Peter A. Friedli Chairman
Frank D. Czworka Chief Operating Officer
Linda L. Chang Chief Financial Officer
Alla Danilkovitch Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
OSIRIS THERAPEUTICS, I..207
AMGEN17.19%122 290
CELGENE CORPORATION14.76%98 556
GILEAD SCIENCES-5.74%85 708
REGENERON PHARMACEUTIC..34.93%52 649
VERTEX PHARMACEUTICALS83.02%31 465
More Results